We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
GPRC5D-Targeted Bispecifics in Relapsed/Refractory Multiple Myeloma: Practical Expert Consensus on a New Target with Unique Adverse Events
Jeffrey V. Matous, MD
Donna Catamero, NP
Ajai Chari, MD
Applying SDM to Personalize Treatment Discussions on Recurrence Risk Reduction in Patients with Early-Stage Melanoma
Meghan Mooradian, MD
ADCs in Gynecologic Cancers: Managing Pulmonary and Cardiac TEAEs
Susana Campos, MD, MPH
ADCs on the Horizon for Breast Cancer: Managing Treatment-Emergent Toxicities
Nadia Harbeck, MD, PhD
ADC-Related Hematologic Adverse Events
Egbert Smit, MD
Hematologic Adverse Events With ADCs in Breast Cancer: Optimal Management Strategies
Managing ADC-Related Pulmonary and Cardiac AEs in NSCLC
Optimal Management of ADC-Related Gastrointestinal AEs in NSCLC
Gastrointestinal and Hematologic TEAEs Related to ADC Therapy in Gynecologic Cancers
Mastering the AEs of ADCs to Unlock Their Full Potential in Breast, Lung, and Gynecologic Cancer
Emerging ADC Therapies for NSCLC: Anticipating AEs Reported in Clinical Trials
Managing Pulmonary and Cardiac Adverse Events Related to ADC Therapy in Breast Cancer
Risk Reduction and Management Protocols for Gastrointestinal Adverse Events With ADC Therapy in Breast Cancer
Cracking the CRS Code in Myeloma: Insights from a Comprehensive Case Review
Caitlin Costello, MD
Sagar Lonial, MD, FACP
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education